-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B81U3RrFjRtNoEv8CrvpzqdtFEIXaZVkLhzbBvj0LlT5gFAXiGuslhLRfzAzlmpl KZfUiNK9KhY4GsuMPV6Xdg== 0001341150-05-000014.txt : 20051101 0001341150-05-000014.hdr.sgml : 20051101 20051101132254 ACCESSION NUMBER: 0001341150-05-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051031 FILED AS OF DATE: 20051101 DATE AS OF CHANGE: 20051101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC DATE OF NAME CHANGE: 19960710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anacone Robert CENTRAL INDEX KEY: 0001341150 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 051169038 BUSINESS ADDRESS: BUSINESS PHONE: 858-805-2724 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2005-10-31 0 0000834306 BIOSITE INC BSTE 0001341150 Anacone Robert 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 1 SR VP - Worldwide Mktg./Sales SR VP - Worldwide Mktg./Sales Non-Qualified Stock Option (right to buy) 55.23 2005-10-31 4 A 0 50000 0 A 2015-10-31 Common Stock 50000 50000 D Option vests in sixteen equal quarterly installments over four years (on each quarterly anniversary of the applicable vesting commencement date), provided that no shares may be exercised during the first six (6) month period following the commencement of vesting. By: Robyn Shutak For: Robert B. Anacone 2005-10-31 -----END PRIVACY-ENHANCED MESSAGE-----